MLABNasdaqIndustrial Instruments For Measurement, Display, and ControlFiscal year ends March 31
MESA LABORATORIES INC /CO/
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$123.31+0.83 (+0.67%)
Close on Oct 19, 2026
- Market cap
- $709.87M
- P/E (TTM)
- 145.1
- Dividend yield
- 0.52%
MESA LABORATORIES INC /CO/ revenue by segment
By business segment
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sterilization and Disinfection Control [Member] | $101.57M | $93.42M | $75.12M | $64.61M | $59.04M | $53.12M | $49.66M | $46.30M | – | – | 40.8% | +8.7% |
| Calibration Solutions [Member] | $53.55M | $51.75M | $47.76M | $44.81M | $46.87M | $46.93M | $51.71M | – | – | – | 21.5% | +3.5% |
| Biopharmaceutical Development [Member] | $48.63M | $48.73M | $40.71M | $47.37M | $45.58M | $33.89M | $13.85M | $0 | – | – | 19.5% | -0.2% |
| Clinical Genomics [Member] | $45.39M | $47.08M | $52.59M | $62.30M | $32.84M | $0 | $0 | – | – | – | 18.2% | -3.6% |
| Instruments [Member] | – | – | – | – | – | $32.47M | $37.98M | $36.13M | $34.10M | $34.41M | – | – |
| Biological Indicators [Member] | – | – | – | – | – | – | – | – | – | $38.64M | – | – |
| Cold Chain Monitoring [Member] | – | – | – | – | – | $14.46M | $13.73M | $13.81M | $12.98M | $12.58M | – | – |
| Cold Chain Packaging [Member] | – | – | – | – | – | – | – | $6.91M | $5.84M | $8.04M | – | – |
| Sterilzation and Disinfection Control [Member] | – | – | – | – | – | – | $49.66M | $46.30M | $43.26M | $38.64M | – | – |
| Continuous Monitoring [Member] | – | – | – | – | – | $14.46M | $13.73M | $13.81M | $12.98M | – | – | – |
By product or service
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $203.39M | $198.40M | $176.80M | $180.52M | $149.42M | $107.03M | $93.40M | $81.80M | $74.39M | $73.51M | 81.6% | +2.5% |
| Service [Member] | $45.74M | $42.58M | $39.39M | $38.56M | $34.91M | $26.91M | $24.29M | $21.34M | $21.79M | $20.16M | 18.4% | +7.4% |
By region
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $116.90M | $116.62M | $106.40M | $117.28M | $99.07M | $71.39M | $66.34M | $64.83M | $57.00M | $52.99M | 46.9% | +0.2% |
| Other [Member] | $111.79M | $99.05M | $84.86M | $76.00M | $68.75M | $55.94M | – | – | – | – | 44.9% | +12.9% |
| China | $20.45M | $25.31M | $24.93M | $25.80M | $16.52M | $6.61M | – | – | – | – | 8.2% | -19.2% |
| Foreign [Member] | – | – | – | – | – | – | – | – | – | $40.68M | – | – |
| Non-US [Member] | – | – | – | – | $85.27M | $62.55M | $51.34M | $38.31M | $39.18M | $40.68M | – | – |
From the segment and revenue-disaggregation notes of Mesa Laboratories's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.